Chris Campbell Discusses The Importance Of Patient Advocacy (Video)

A new study in The Lancet has shown that adding a drug called pembrolizumab to standard treatments can improve survival for people with certain types of soft tissue cancers. These cancers, known as undifferentiated pleomorphic sarcoma, dedifferentiated liposarcoma, and pleomorphic read more about A Clinical Trial Improved Survival for Certain Sarcoma Cancers